NVIDIA has successfully acquired arm, the Financial Times reported on August 15. The purchase amount has been fixed, but the specific amount has not been disclosed. According to people familiar with the matter, the acquisition will be completed by the end of the month and could value arm as much as 40 billion pounds. Arm company is an intellectual property supplier. The biggest difference between arm and other semiconductor companies is that it does not manufacture chips and does not sell chips to end users. Instead, it transfers design solutions and produces chips with different characteristics by partners. < / P > < p > at present, more than 100 companies have signed technology license agreements with arm companies, including Intel, IBM, LG, NEC, Sony, NXP and ns. As for the partners of software systems, they include a series of well-known companies such as Microsoft, Shengyang and MRI. As early as April this year, arm, headquartered in Cambridge, UK, was listed for the first time by Softbank, its Japanese parent company, when Goldman Sachs, the US investment bank, was hired to look for potential buyers. Softbank was in a difficult situation at that time. After the investment failure of Wework, a start-up enterprise with shared office space, Softbank suffered serious losses. Goldman Sachs initially approached apple, but the latter was not interested in acquiring arm. The bank then tried to form a consortium, including Qualcomm, Google, Samsung and NVIDIA, all of which will take a stake in arm. In the end, however, NVIDIA became the only interested buyer. < / P > < p > in addition, the acquisition may be subject to severe scrutiny by the UK government. The evening news said the British government would prefer to keep arm at home to increase employment. < / P > < p > so far, all parties have declined to comment on the news. The report also pointed out that if the deal is concluded, it may lead to tension between Britain and Japan. Britain plans to seek a quick trade deal with Japan before leaving the EU next year. American companies begin to give up R & D: who should pay for corporate research?